Friday, November 22, 2024
HomeTagsCell Therapies

Cell Therapies

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell (TCR-T) therapeutics company, and Shinobi Therapeutics (Shinobi), developer of immune-evasive induced pluripotent stem cell (iPSC)-derived CD8...

Multiply Labs and Retro Biosciences Announce an $85 Million Partnership to Advance Cell Therapy Manufacturing for Age-Related Diseases

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Retro Biosciences (Retro), a biotechnology company developing therapies that meaningfully...

Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing

Mekonos, Inc., a biotech platform company building the future of cell engineering on a chip, announced it has entered into a partnership agreement with...

Twist Bioscience Launches TCR and CAR Libraries to Enable the Development of Cell Therapies

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the launch...

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T

Precigen, Inc, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced the amendment...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics